John Potthoff

Exploring new ways to smooth the path toward better participation for patients and other research and healthcare stakeholders.

Clinical research must deploy innovative, disruptive approaches without disrupting patients.

IntroductionAfter decades of promise, we have begun to realize the fruit of “-omics” technology. Recent advances in proteomics, genomics and metabolomics have enabled us to understand the molecular basis of disease at both the diagnostic and treatment levels. Equally important, a growing suite of biomarkers now provides predictive value for diagnosis, disease progression and cure/remission.